Skip to main content

Mark Krauthammer, MD, MBA

  • Cornea Fellow

Dr. Krauthammer earned his medical degree in Israel and completed his ophthalmology residency at Tel Aviv Medical Center. Driven by a special interest in corneal disease and transplantation, he went on to fellowship training in cataract, cornea, and anterior segment disease. He then moved to Boston to pursue advanced research training in corneal immunology, spending three years as a research fellow at the Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School. He is excited to join UPMC as a Cornea Fellow. His clinical and research interests include corneal immunology, corneal infections, corneal transplantation, and refractive surgery.

Division

    Education & Training

  • 2023-2026 Corneal Immunology Research Fellowship - Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • 2019-2020 Cataract, Cornea and Anterior Segment Diseases Clinical Fellowship - Tel-Aviv Medical Center, Tel-Aviv, Israel
  • 2014-2019 Ophthalmology Residency - Tel-Aviv Medical Center, Tel-Aviv, Israel
  • 2006-2013 Medical School - Ben-Gurion University of the Negev, Beer Sheva, Israel
Awards
2026 Winner of Harvard Ophthalmology Annual Trainee Poster Contest
Representative Publications

Is Demodex Blepharitis Connected With Cataract Surgery? Feldman I, Krausz J, Levinkron O, Gutovitz J, Edison N, Cohen E, Krauthammer M, Briscoe D.Am J Ophthalmol. 2023 Oct;254:31-35. doi: 10.1016/j.ajo.2023.05.016. Epub 2023 May 29.PMID: 37257549

SYRINGE DESIGN AND FILLING TECHNIQUE AFFECT ACCURACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTIONS. Krauthammer M, Harel G, Moisseiev E.Retina. 2023 Mar 1;43(3):514-519. doi: 10.1097/IAE.0000000000003693.PMID: 36729828

Effector T Cells Promote Fibrosis in Corneal Transplantation Failure. Wang S, Mittal SK, Lee S, Herrera AE, Krauthammer M, Elbasiony E, Blanco T, Alemi H, Nakagawa H, Chauhan SK, Dana R, Dohlman TH. Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):40. doi: 10.1167/iovs.65.1.40.PMID: 38261311

Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study. Shragai T, Magen H, Lavi N, Gatt M, Trestman S, Zektser M, Ganzel C, Jarchowsky O, Berger T, Tadmor T, Leiba M, Hertzog-Tzarfaty K, Horowitz N, Shapira M, Varssano D, Berger Y, Frenkel S, Krauthammer M, Avivi I, Luttwak E, Cohen YC; Israeli myeloma study group. Br J Haematol. 2023 Jan;200(1):45-53. doi: 10.1111/bjh.18479. Epub 2022 Oct 7.PMID: 36205375

Acquired immunostimulatory phenotype of migratory CD103+ DCs promotes alloimmunity following corneal transplantation. Blanco T, Nakagawa H, Musayeva A, Krauthammer M, Singh RB, Narimatsu A, Ge H, Shoushtari SI, Dana R.JCI Insight. 2024 Oct 22;9(20):e182469. doi: 10.1172/jci.insight.182469.PMID: 39235864

Full list of publications